Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4017 in raised intra-ocular pressure and primary open angle glaucoma
2010-020932-20Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ocular hypertension and open-angle glaucoma (OAG) comparing AZD4017 with Placebo (2 arms). Primary endpoint: Percentage decrease from baseline in IOP at endpoint. Started Jun 2010; status: completed.
02
Drugs
AZD4017
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2010-020932-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020932-20.